GastroenterologyNews.net

Gastroenterology Xagena

Search results for "Inflammatory bowel disease"

IBD ( inflammatory bowel diseases ) is a term referring to several chronic diseases that cause inflammation of the intestines, including ulcerative colitis and Crohn's disease. Symptoms for both con ...


A open-label study carried out by physicians at New York-Presbyterian Hospital / Weill Cornell Medical Center showed that there may be a new application for the antibiotic Rifaximin ( Xifaxan ) in tr ...


Infliximab is the first biologic to show efficacy in two inflammatory bowel diseases ( IBD ), Crohn's Disease and ulcerative colitis. Results from two Phase III trials presented at Digestive Diseas ...


Treatment with a recombinant form of a hematopoietic growth factor GM-CSF, Sargramostim ( Leukine ), significantly reduced symptom severity and improved quality of life after 56 days of daily drug i ...


The results from a double-blind, multicenter phase II trial of the investigational drug MLN02 in patients with ulcerative colitis showed that MLN02 was more effective than placebo for the induction of ...


Most treatments for Crohn's, an autoimmune disorder, are geared to suppress the immune response, but a new study demonstrates that stimulating innate immunity also is effective at improving symptoms i ...


Two studies, published in the Clinical Gastroenterology and Hepatology, have showen that prescription painkillers are effective in easing the pain of patients with dormant inflammatory bowel disease ( ...


A study found that the risk of infertility in women triples after the most major surgery for the inflammatory bowel disease ulcerative colitis. The authors base their finding on a detailed analysi ...


Takeda Pharmaceutical has announced top-line results from the international, randomized, placebo-controlled, double-blind GEMINI II pivotal phase 3 trial. The trial has evaluated Vedolizumab in 1,11 ...


Safe, effective treatment options exist for patients with mild-to-moderate Crohn’s disease or ulcerative colitis. However, a significant proportion of patients with moderate-to-severe Crohn’s disease ...


Crohn’s disease and ulcerative colitis are chronic, relapsing inflammatory disorders of the gastrointestinal ( GI ) tract. In both Crohn’s disease and ulcerative colitis, leukocytic infiltration of th ...


Diverticulitis is a common disease. Recent changes in understanding its natural history have substantially modified treatment paradigms. It has been reviewed the etiology and natural history of div ...


The safety and efficacy of Adalimumab ( Humira ) for patients with moderately to severely active ulcerative colitis has been reported up to week 52 from the placebo-controlled trials ULTRA ( Ulcerativ ...


TOUCHSTONE, the phase 2 trial of RPC1063 in ulcerative colitis ( UC ), met its primary endpoint and all secondary endpoints with statistical significance in patients on the 1 mg dose of RPC1063 in the ...


TNF inhibitors are effective in the treatment of ulcerative colitis. Adalimumab ( Humira ), a fully human TNF inhibitor, is increasingly used both as primary anti-TNF agent and in patients switching f ...